Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wellstein

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|August 18, 2001
Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding proteinE Tassi, A Al-Attar, A Aigner, et al.
Gene Therapy|October 22, 2004
Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approachC Malerczyk, A M Schulte, F Czubayko, et al.
Clinical Pharmacology and Therapeutics|October 1, 1991
AF-DX 116, a cardioselective muscarinic antagonist in humans: pharmacodynamic and pharmacokinetic propertiesB Schulte, C Volz-Zang, E Mutschler, et al.
Nature Medicine|October 23, 1997
A secreted FGF-binding protein can serve as the angiogenic switch in human cancerF Czubayko, E D Liaudet-Coopman, A Aigner, et al.
British Journal of Clinical Pharmacology|November 1, 1988
Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflexG G Belz, J Essig, C H Kleinbloesem, et al.
Breast Cancer Research and Treatment|January 1, 1995
Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophinF Czubayko, A M Schulte, S C Missner, et al.
Journal of the National Cancer Institute|July 7, 1993
Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfateB W Parker, S M Swain, G Zugmaier, et al.
Journal of the National Cancer Institute|October 17, 1998
Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumorsB Souttou, H Juhl, J Hackenbruck, et al.
Gene Therapy|February 12, 1998
Adenovirus-mediated transduction of ribozymes abrogates HER-2/neu and pleiotrophin expression and inhibits tumor cell proliferationF Czubayko, S G Downing, S S Hsieh, et al.
Oncogene|August 30, 2000
Influence of the human endogenous retrovirus-like element HERV-E.PTN on the expression of growth factor pleiotrophin: a critical role of a retroviral Sp1-binding siteA M Schulte, C Malerczyk, R Cabal-Manzano, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|August 18, 2001
Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding proteinE Tassi, A Al-Attar, A Aigner, et al.
Gene Therapy|October 22, 2004
Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approachC Malerczyk, A M Schulte, F Czubayko, et al.
Clinical Pharmacology and Therapeutics|October 1, 1991
AF-DX 116, a cardioselective muscarinic antagonist in humans: pharmacodynamic and pharmacokinetic propertiesB Schulte, C Volz-Zang, E Mutschler, et al.
Nature Medicine|October 23, 1997
A secreted FGF-binding protein can serve as the angiogenic switch in human cancerF Czubayko, E D Liaudet-Coopman, A Aigner, et al.
British Journal of Clinical Pharmacology|November 1, 1988
Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflexG G Belz, J Essig, C H Kleinbloesem, et al.
Breast Cancer Research and Treatment|January 1, 1995
Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophinF Czubayko, A M Schulte, S C Missner, et al.
Journal of the National Cancer Institute|July 7, 1993
Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfateB W Parker, S M Swain, G Zugmaier, et al.
Journal of the National Cancer Institute|October 17, 1998
Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumorsB Souttou, H Juhl, J Hackenbruck, et al.
Gene Therapy|February 12, 1998
Adenovirus-mediated transduction of ribozymes abrogates HER-2/neu and pleiotrophin expression and inhibits tumor cell proliferationF Czubayko, S G Downing, S S Hsieh, et al.
Oncogene|August 30, 2000
Influence of the human endogenous retrovirus-like element HERV-E.PTN on the expression of growth factor pleiotrophin: a critical role of a retroviral Sp1-binding siteA M Schulte, C Malerczyk, R Cabal-Manzano, et al.
Pageof 11